What is Opus Genetics's exercised (in shares)?

Opus Genetics (IRD) reported exercised (in shares) of 0 in Q1 2026.

What does exercised (in shares) mean?

The total number of equity instruments, excluding standard options, that were exercised by holders during the reporting period. This reflects the conversion of incentive awards into actual shares of common stock. It is a primary driver of share count dilution and employee liquidity events.

Opus Genetics IRD Exercised (in shares)

Exercised (in shares) at other companies

Medline, Inc. MDLN

$0.00—

XylemXYL

$45.33-31.0%

Cadence Design SystemsCDNS

$93.81+29.9%

F5, Inc.FFIV

$37.28+25.8%

Vertex PharmaceuticalsVRTX

$125.30—

Charles River LaboratoriesCRL

$179.66—

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept ird:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's exercised (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's exercised (in shares)?: Opus Genetics (IRD) reported exercised (in shares) of 0 in Q1 2026.
What does exercised (in shares) mean?: The total number of equity instruments, excluding standard options, that were exercised by holders during the reporting period. This reflects the conversion of incentive awards into actual shares of common stock. It is a primary driver of share count dilution and employee liquidity events.